Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line

Anna Maria Mileo1, Donato Di Venere, Vito Linsalata

  • 1Department of Development of Therapeutic Programs, Regina Elena National Cancer Institute, Rome, Italy.

Insights

Artichoke extracts (AEs) show antitumor effects against estrogen receptor-negative breast cancer cells by inducing apoptosis and inhibiting growth. AEs demonstrated potential chemopreventive activity without harming normal cells.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Estrogen receptor-negative breast cancer, such as the MDA-MB231 cell line, presents a significant therapeutic challenge.
  • Polyphenolic compounds from edible plants are increasingly investigated for their potential health benefits and anticancer properties.

Purpose of the Study:

  • To investigate the antitumor effects of artichoke (Cynara scolymus) polyphenol extracts (AEs) on the MDA-MB231 human breast cancer cell line.
  • To determine if AEs induce apoptosis and inhibit the invasive potential of these cancer cells.
  • To compare the effects of AEs with its main component, chlorogenic acid (ChA).

Main Methods:

  • Treatment of MDA-MB231 and MCF10A cells with varying concentrations of AEs and ChA.
  • Assessment of cell viability, proliferation, apoptosis (caspase activation, Bax:Bcl2 ratio, p21(WAF1) expression, mitochondrial potential), cell motility, invasion, and matrix metalloproteinase-2 (MMP-2) activity.
  • Utilized Western blotting, flow cytometry, and other biochemical assays.

Main Results:

  • AEs significantly reduced MDA-MB231 cell viability and inhibited proliferation in a dose-dependent manner.
  • AEs induced apoptosis through both mitochondrial (caspase-9 activation, loss of mitochondrial potential) and death-receptor (caspase-8 activation) pathways, with increased Bax:Bcl2 ratio and p21(WAF1) expression.
  • AEs markedly inhibited cell motility, invasion, and MMP-2 activity in MDA-MB231 cells, while showing no toxicity to normal MCF10A cells. Chlorogenic acid alone had minimal impact.

Conclusions:

  • Artichoke polyphenol extracts possess significant antitumor properties against estrogen receptor-negative breast cancer cells.
  • AEs effectively induce apoptosis and suppress the invasive phenotype of MDA-MB231 cells.
  • These findings suggest that artichoke extracts have potential as a chemopreventive agent against breast cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...